The Hemophilia Alliance
Board of Directors
1758 Allentown Road #183
Lansdale, PA 19446
Dear Board of Directors of the Hemophilia Alliance:
We are writing to affirm Pfizer’s belief that patients living with hemophilia should have access to providers who are experts in treating this serious and complex disease.
The National Hemophilia Foundation (NHF) back in 1973 launched an initiative to establish Hemophilia Treatment Centers (HTC) to bring the comprehensive care needed by hemophilia patients into one facility. The comprehensive care provided by Hemophilia Treatment Centers (HTCs) has been shown in studies to have a positive effect on patient outcomes.
In order for a patient to access the full range of services provided by the HTC they need health insurers to include HTC’s in the provider networks.
Pfizer has a long history of supporting the hemophilia community. We understand the medicines and resources we provide are one part of the effort needed to support patients with hemophilia and their families. The comprehensive care that patients receive from the HTC helps them lead a more normal life. In order for patients to continue to benefit from this care it is critical that insurance providers include HTC’s in the provider networks.
Sincerely,
Karen Boykin-Towns
Vice President, Corporate Affairs
Pfizer’s letter of support: Click here.